Textbook in PDF format This volume examines regenerative medicine (RM) through a global bioethics lens that foregrounds the structural asymmetries, epistemic exclusions, and governance disparities shaping its development and uptake. RM refers to a range of innovative therapies, clinical interventions, and research activities aimed at repairing or replacing damaged or diseased human cells, tissues, and organs, with an emphasis on conditions currently considered incurable. While RM is often discussed using examples, standards, and governance models from high-income countries (the so-called “Global North”), much less is documented about its realities in low- and middle-income countries (LMICs), particularly in the “Global South.” These contexts are frequently overlooked in ways that understate their contributions, impose ill-fitting external frameworks, or perpetuate assumptions of absence or inactivity. Such omissions contribute to epistemic injustice, in which certain perspectives, priorities, and knowledge systems are marginalized in global health innovation